| Cover | Feb. 14, 2025 |
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Current Report on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K (the “Original 8-K”) that was filed by NeuroOne Medical Te hnologies Corporation (the “Company”) with the Securities and Exchange Commission on February 14, 2025. The Company is filing this Amendment only to include Item 5.02 to provide information about the NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan, which was approved by the Company’s stockholders at the annual meeting of the stockholders held on February 14, 2025, as disclosed in Item 5.07 of the Original 8-K, and to file the NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan and NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan Forms of Restricted Stock Unit Agreement and Option Grant Agreement as exhibits hereto. This Amendment amends and restates the Original 8-K in its entirety. |
| Document Period End Date | Feb. 14, 2025 |
| Entity File Number | 001-40439 |
| Entity Registrant Name | NeuroOne Medical Technologies Corporation |
| Entity Central Index Key | 0001500198 |
| Entity Tax Identification Number | 27-0863354 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 7599 Anagram Dr. |
| Entity Address, City or Town | Eden Prairie |
| Entity Address, State or Province | MN |
| Entity Address, Postal Zip Code | 55344 |
| City Area Code | 952 |
| Local Phone Number | 426-1383 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.001 per share |
| Trading Symbol | NMTC |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
